Vaginal Ring for Hormone Therapy, Prevention of Preterm Labor & Luteal Phase Support During ART
Time: 2:45 pm
day: Day 1
Details:
- Focusing on use of a novel segmented intravaginal ring (IVR) to deliver estradiol and progesterone over 28 days for treatment of vasomotor symptoms associated with the menopause
- Exploring the segmented IVR to reduce the incidence of preterm labor by delivery of vaginal progesterone
- Understanding the use of the segmented IVR for its use in the luteal phase support during ART including combinations with injectable progesterone
